Efficacy and safety of chemotherapy combined with different doses of IL-2 maintenance therapies for acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of chemotherapy combined with different doses of IL-2 maintenance therapies for acute myeloid leukemia

Published:2021-06-11 Issue:23 Volume:100 Page:e26098
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Yin Xuewei,Ding Yi,Yu Liming,Guo Chenchen,Cui Yanyan,Zhai Xixi,Wang Yan,Ding Shumin,Shen Mingyue,Li Zonghong,Xu Ruirong

Funder

National Natural Science Foundation of China

Key project of Shandong Natural Science Foundation

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference23 articles.

1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017

2. Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia;Qu;Leuk Res,2015

3. Effects of recombinant human interleukin-2 activated natural killer cells on cardiac function in rats with myocardial infarction;Wang;Zhonghua Xin Xue Guan Bing Za Zhi,2013

4. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer;Rosenberg;N Engl J Med,1985

5. Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808;Kolitz;Cancer,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP